Is albumin infusion indicated for a patient with cirrhosis and ascites?

Albumin Transfusion in Cirrhosis with Ascites

Albumin is NOT routinely indicated for cirrhosis with uncomplicated ascites, but IS mandatory for specific high-risk situations: large-volume paracentesis >5L, spontaneous bacterial peritonitis, and hepatorenal syndrome. 1, 2

When Albumin IS Indicated

Large-Volume Paracentesis (Primary Indication)

• Administer 8 g of albumin per liter of ascites removed after completing paracentesis of >5 liters (using 20% or 25% albumin solution) 3, 2
• This prevents post-paracentesis circulatory dysfunction, which can lead to renal failure, hepatorenal syndrome, dilutional hyponatremia, and hepatic encephalopathy 2, 4
• High-quality evidence demonstrates significant reduction in adverse effects and mortality with this approach 2
• For paracentesis <5L, consider albumin only in high-risk patients with acute-on-chronic liver failure or elevated risk of acute kidney injury 3, 2

Spontaneous Bacterial Peritonitis (SBP)

• Give 1.5 g/kg albumin within 6 hours of SBP diagnosis, followed by 1.0 g/kg on day 3 3, 1, 2
• This protocol reduces hepatorenal syndrome incidence and mortality 2
• Patients with bilirubin ≥4 mg/dL or creatinine ≥1 mg/dL benefit most 2
• Do NOT use albumin for non-SBP infections in cirrhotic patients—it provides no benefit and increases pulmonary edema risk 2

Hepatorenal Syndrome

• Albumin is used as part of vasoconstrictor therapy in hepatorenal syndrome 1

When Albumin Is NOT Indicated

Uncomplicated Ascites (Critical Pitfall)

• Multiple guidelines explicitly recommend AGAINST albumin for hospitalized or outpatient cirrhotic patients with uncomplicated ascites or hypoalbuminemia alone 1
• The ATTIRE trial demonstrated no benefit in preventing infection, acute kidney injury, or death, and was associated with increased pulmonary edema 1
• The MACHT trial in advanced cirrhosis patients awaiting transplant found no mortality benefit 1
• Up to 45% of patients may experience cardiovascular events with albumin use 1

Standard Ascites Management Instead

• First-line treatment: sodium restriction (≤2 g/day) plus diuretics 3, 2
• Start with spironolactone 100 mg daily (increase to 400 mg) for uncomplicated ascites 3
• For recurrent severe ascites or hospitalized patients needing faster diuresis: combine spironolactone (100-400 mg) with furosemide (40-160 mg) 3
• Monitor closely for adverse events—nearly half of patients require dose adjustment or discontinuation 3

Special Circumstances Requiring Caution

Hyponatremia Management

• For serum sodium 126-135 mmol/L: continue diuretics, no intervention needed 2
• For sodium 121-125 mmol/L with elevated/rising creatinine: stop diuretics and give albumin for volume expansion 2
• For sodium <120 mmol/L: stop diuretics, provide albumin/colloid, but avoid increasing sodium >12 mmol/L per 24 hours to prevent central pontine myelinolysis 2
• Do NOT routinely restrict fluids unless sodium <125 mmol/L with clinical hypervolemia—fluid restriction worsens effective hypovolemia 2

Fluid Selection

• Never use normal saline for routine volume expansion in cirrhotic ascites—it contains 154 mmol/L sodium and worsens fluid overload 3, 2
• Albumin is the preferred colloid over crystalloids for volume expansion 2
• Artificial plasma expanders and hydroxyethyl starch are inferior to albumin 2

Evidence Quality and Controversies

The evidence shows clear divergence between established indications and emerging research:

• Strong evidence (high quality): Albumin for large-volume paracentesis reduces complications 3, 2, 5
• Moderate evidence: Albumin in SBP reduces mortality 3, 2
• Contradictory evidence: While older studies suggested benefit from long-term albumin administration 6, recent high-quality trials (ATTIRE, MACHT) showed no benefit and potential harm in routine use 1
• The 2021 British Society of Gastroenterology guidelines and 2025-2026 American Association for the Study of Liver Diseases recommendations consistently emphasize limiting albumin to specific indications only 3, 1, 2

Monitoring Requirements

• Monitor all patients on diuretics for adverse events including hypovolemic hyponatremia, renal impairment, and electrolyte disturbances 3
• Discontinue diuretics for hypovolemic hyponatremia and expand plasma volume 3
• Reserve hypertonic saline (3%) only for severely symptomatic acute hyponatremia with slow correction 3, 2